NCT01881048 2026-01-29
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
Clinical Trials
17 trialsNCT03084536 2024-12-24
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Washington University School of Medicine
Phase 2 Completed
NCT04081389 2023-09-11
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT03599453 2023-07-18
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT05438303 2023-01-12
Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
AstraZeneca
Phase 1 Completed
NCT02429427 2020-06-23
REACT
Imperial College London
Phase 3 Completed
NCT01695226 2018-01-09
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer
Maastricht University Medical Center
Phase 2 Completed
NCT01425476 2017-08-09
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Hartford Hospital
Phase 1/2 Completed
NCT01769625 2017-08-09
Changes in Biomarkers Using Prostaglandin Inhibitors
Hartford Hospital
Phase 1/2 Completed
NCT00056082 2017-02-15
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT00070057 2016-12-29
Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00201773 2015-06-30
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00006381 2013-12-19
Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00135018 2012-05-24
Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer
Organisation for Oncology and Translational Research
Phase 2 Completed
NCT00525096 2011-06-30
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 3 Completed
NCT00328432 2008-09-17
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
University of Kansas Medical Center
Phase 1 Completed
NCT00291122 2008-09-16
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer
University of Kansas Medical Center
Completed